Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Debruyne

Showing results (41-50 of 505) with videos related to

Pageof 51
Sort By:
Current Opinion in Urology|August 9, 2001
Can biological markers replace cystoscopy? An updateH G van der Poel, F M Debruyne
Revue Medicale De La Suisse Romande|September 1, 1992
Diagnostics and treatment of prostatitis: an actualized overviewJ J de la Rosette, F M Debruyne
Chemotherapy|January 1, 1985
Ciprofloxacin distribution in prostatic tissue and fluid following oral administrationJ B Boerema, A Dalhoff, F M Debruyne
European Urology|January 1, 1993
Transurethral microwave thermotherapy in symptomatic benign prostatic hyperplasiaR Laduc, F A Bloem, F M Debruyne
Seminars in Oncology|February 1, 1995
The use of monoclonal antibody G250 in the therapy of renal-cell carcinomaE Oosterwijk, F M Debruyne, J A Schalken
Journal of Endourology|November 18, 2000
Microwave thermotherapy: historical overviewM P Laguna, R Muschter, F M Debruyne
European Urology|January 1, 1990
Extragonadal germ cell tumor invading the prostateJ J de la Rosette, F M Debruyne
European Urology|July 7, 1999
Clinical experience in Europe with uroselective alpha1-antagonistsF M Debruyne, H G Van der Poel
Urology|March 1, 1997
Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate CancerW P Witjes, C C Schulman, F M Debruyne
Urologic Oncology|January 13, 2011
Induction of tumor regression by passive transfer of antibody from mice vaccinated with anti-idiotype antibodies resembling a human renal cell carcinoma-associated antigenH Uemura, E Okajima, F M Debruyne, et al.
Pageof 51

Showing results (41-50 of 505) with videos related to

Sort By:
Pageof 51
Current Opinion in Urology|August 9, 2001
Can biological markers replace cystoscopy? An updateH G van der Poel, F M Debruyne
Revue Medicale De La Suisse Romande|September 1, 1992
Diagnostics and treatment of prostatitis: an actualized overviewJ J de la Rosette, F M Debruyne
Chemotherapy|January 1, 1985
Ciprofloxacin distribution in prostatic tissue and fluid following oral administrationJ B Boerema, A Dalhoff, F M Debruyne
European Urology|January 1, 1993
Transurethral microwave thermotherapy in symptomatic benign prostatic hyperplasiaR Laduc, F A Bloem, F M Debruyne
Seminars in Oncology|February 1, 1995
The use of monoclonal antibody G250 in the therapy of renal-cell carcinomaE Oosterwijk, F M Debruyne, J A Schalken
Journal of Endourology|November 18, 2000
Microwave thermotherapy: historical overviewM P Laguna, R Muschter, F M Debruyne
European Urology|January 1, 1990
Extragonadal germ cell tumor invading the prostateJ J de la Rosette, F M Debruyne
European Urology|July 7, 1999
Clinical experience in Europe with uroselective alpha1-antagonistsF M Debruyne, H G Van der Poel
Urology|March 1, 1997
Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate CancerW P Witjes, C C Schulman, F M Debruyne
Urologic Oncology|January 13, 2011
Induction of tumor regression by passive transfer of antibody from mice vaccinated with anti-idiotype antibodies resembling a human renal cell carcinoma-associated antigenH Uemura, E Okajima, F M Debruyne, et al.
Pageof 51